NCT02305017View on ClinicalTrials.gov

Effect of Paracetamol on Opicapone Pharmacokinetics in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Parkinson's Disease
Interventions
DRUG

BIA 9-1067

BIA 9-1067 50 mg

DRUG

Paracetamol

Paracetamol 1g

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT02305017 - Effect of Paracetamol on Opicapone Pharmacokinetics in Healthy Volunteers | Biotech Hunter | Biotech Hunter